Care Access Research-Walnut Creek

Walnut Creek, California 94589

We've found

3 trials

at this facility

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Walnut Creek, CA

A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Walnut Creek, CA

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

Walnut Creek, CA

Use our guide to learn which trials are right for you!